Partial glucocorticoid agonist-like effects of imipramine on hypothalamic-pituitary-adrenocortical activity, thymus weight, and hippocampal glucocorticoid receptors in male C57BL/6 mice

Endocrinology

Volumn 145, Issue 9, 2004, Pages 4185-4191

  Mukherjee, Koustav ^a   Knisely, Anna ^a   Jacobson, Lauren ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMIPRAMINE; SODIUM CHLORIDE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; FORCED SWIMMING TEST; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; THYMUS;

ADRENALECTOMY; ADRENERGIC UPTAKE INHIBITORS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; DEPRESSIVE DISORDER; GLUCOCORTICOIDS; HIPPOCAMPUS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMIPRAMINE; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; ORGAN SIZE; PITUITARY-ADRENAL SYSTEM; RECEPTORS, GLUCOCORTICOID; STRESS; SWIMMING;

EID: 4344584069     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2004-0147     Document Type: Article

References (46)

1. Pariante CM, Miller AH 2001 Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 49:391-404
2. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R 2003 Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389
3. Hatzinger M, Hemmeter UM, Baumann K, Brand S, Holsboer-Trachsler E 2002 The combined DEX-CRH test in treatment course and long-term outcome of major depression. J Psychiatr Res 36:287-297
4. Deuschle M, Hamann B, Krumm CM, Lederbogen F, Kniest A, Colla M, Heuser I 2003 Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations. J Clin Psychopharmacol 23:201-205
5. Clayton PJ 1998 Depression subtyping: treatment implications. J Clin Psychiatry 59(Suppl 16):5-12
6. Belanoff JK, Rothschild AJ, Cassidy F, DeBattista C, Baulieu E-E, Schold C, Schatzberg AF 2002 An open-label trial of C-1073 (Mifepristone) for psychotic major depression. Biol Psychiatry 52:386-392
7. Loosen PT 2002 Psychiatric manifestations of Cushing's syndrome. In: Blevins LS, ed. Cushing's syndrome. Boston: Kluwer Academic; 45-64
8. Starkman MN, Schteingart DE 1981 Neuropsychiatric manifestations of patients with Cushing's syndrome: relationship to cortisol and adrenocorticotropic hormone levels. Arch Intern Med 141:215-219
9. Lewis DA, Smith RE 1983 Steroid-induced psychiatric syndromes. J Affect Disord 5:319-332
10. Brady LS, Whitfield Jr HJ, Fox RJ, Gold PW, Herkenham M 1991 Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain: therapeutic implications. J Clin Invest 87:831-837
11. Gómez F, Graugés P, Martín M, Armario A 1998 The effect of chronic administration of antidepressants on the circadian pattern of corticosterone in the rat. Psychopharmacology (Berl) 140:127-134
12. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council 1996 Guide for the Care and Use of Laboratory Animals. Washington, DC: National Academy Press
13. Cryen JF, Markou A, Lucki I 2002 Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238-245
14. Conti AC, Kuo Y-C, Blendy JA 2004 Inducible cAMP early repressor regulates corticosterone suppression after tricyclic antidepressant treatment. J Neurosci 24:1967-1975
15. Muglia LJ, Jacobson L, Luedke CE, Vogt SK, Schaefer ML, Dikkes P, Fukuda S, Sakai Y, Suda T, Majzoub JA 2000 Corticotropin-releasing hormone links pituitary adrenocorticotropin gene expression and release during adrenal insufficiency. J Clin Invest 105:1269-1277
16. Porsolt RD, Bertin A, Jalfre M 1977 Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327-336
17. Khan AM, Watts AG 2004 Intravenous 2-deoxy-D-glucose injection rapidly elevates levels of the phosphorylated forms of p44/42 mitogen-activated protein kinases (extracellularly regulated kinases 1/2) in rat hypothalamic parvicellular paraventricular neurons. Endocrinology 145:351-359
18. Lucki I 1997 The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8:523-532
19. Dallman MF, Levin N, Cascio CS, Akana SF, Jacobson L, Kuhn RW 1989 Pharmacological evidence that inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors. Endocrinology 124:2844-2850
20. DeFranco DB 2002 Navigating steroid hormone receptors through the nuclear compartment. Mol Endocrinol 16:1449-1455
21. Jacobson L 1999 Lower weight loss and food intake in protein-deprived, CRH-deficient mice correlates with glucocorticoid insufficiency. Endocrinology 140:3543-3551
22. Lai M, McCormick JA, Chapman KE, Kelly PA, Seckl JR, Yau JL 2003 Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture. Neuroscience 118:975-984
23. Herr AS, Tsolakidou AF, Yassouridis A, Holsboer F, Rhein T 2003 Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro. Neuroendocrinology 78:12-22
24. Nestler EJ, Barrot M, Dileone RJ, Eisch AJ, Gold SJ, Monteggia LM 2002 Neurobiology of depression. Neuron 34:13-25
25. Herman JP, Cullinan WE 1997 Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci 20:78-84
26. Sapolsky RM 2000 Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57:925-935
27. Bradbury MJ, Strack AM, Dallman MF 1993 Lesions of the hippocampal efferent pathway (fimbria-fornix) do not alter sensitivity of adrenocorticotropin to feedback inhibition by corticosterone in rats. Neuroendocrinology 58:396-407
28. Müller MB, Lucassen PJ, Yassouridis A, Hoogendijk WJG, Hosboer F, Swaab DF 2001 Neither major depression nor glucocorticoid treatment affects the cellular integrity of the human hippocampus. Eur J Neurosci 14:1603-1612
29. Miller HA, Vogt GJ, Pearce BD 2002 The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function. Neuropsychopharmacology 27:939-948
30. Somers JP, DeFranco DB 1992 Effects of okadaic acid, a protein phosphatase inhibitor, on glucocorticoid receptor-mediated enhancement. Mol Endocrinol 6:26-34
31. Reul JMHM, Stec I, Söder M, Holsboer F 1993 Chronic treatment of rats with the antidepressant amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology 133:312-320
32. Duncan GE, Knapp DJ, Carson SW, Breese GR 1998 Differential effects of chronic antidepressant treatment on swim stress- and fluoxetine-induced secretion of corticosterone and progesterone. J Pharmacol Exp Ther 285:579-587
33. Pariante CM, Hye A, Williamson R, Makoff A, Lovestone S, Kerwin RW 2003 The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurons. Neuropsychopharmacology 28:1553-1561
34. Veldhuis HD, DeKorte CCMM, DeKloet ER 1985 Glucocorticoids facilitate the retention of acquired immobility during forced swimming. Eur J Pharmacol 115:211-217
35. Porsolt RD, Bertin A, Jalfre M 1978 "Behavioral despair" in rats and mice: strain differences and the effects of imipramine. Eur J Pharmacol 51:291-294
36. Akana SF, Shinsako J, Dallman MF 1985 Closed-loop feedback control of the nyctohemeral rise in adrenocortical system function. Fed Proc 44:177-181
37. Keller-Wood ME, Shinsako J, Dallman MF 1983 Integral as well as proportional adrenal responses to ACTH. Am J Physiol 245:R53-R59
38. Akana SF, Dallman MF 1997 Chronic cold in adrenalectomized, corticosterone (B)-treated rats: facilitated corticotropin responses to acute restraint emerge as B increases. Endocrinology 138:3249-3258
39. Tanimura SM, Watts AG 1998 Corticosterone can facilitate as well as inhibit corticotropin-releasing hormone gene expression in the rat paraventricular nucleus. Endocrinology 139:3830-3836
40. Laugero KD, Gomez F, Manalo S, Dallman MF 2002 Corticosterone infused intracerebroventricularly inhibits energy storage and stimulates the hypothalamo-pituitary axis in adrenalectomized rats drinking sucrose. Endocrinology 143:4552-4562
41. Watts AG, Sanchez-Watts G 1995 Region-specific regulation of neuropeptide mRNAs in rat limbic forebrain neurones by aldosterone and corticosterone. J Physiol 484:721-736
42. Baldessarini RJ 2001 Drugs and the treatment of psychiatric disorders: depression and anxiety disorders. In: Hardman JG, Limbard LL, Gilman AG, eds. The pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 457-459
43. Patel YC 2001 Neurotransmitters and hypothalamic control of anterior pituitary function. In: DeGroot LJ, Jameson JL, eds. Endocrinology. 4th ed. Philadelphia: WB Saunders; 183-200
44. Smith CL, Conneely OM, O'Malley BW 1993 Modulation of the ligand-independent activation of the human estrogen receptor by hormone and antihormone. Proc Natl Acad Sci USA 90:6120-6124
45. Felten DL 1993 Direct innervation of lymphoid organs: substrate for neurotransmitter signaling of cells of the immune system. Neuropsychobiology 28:110-112
46. Young EA, Haskett RF, Grunhaus I, Pande A, Weinberg VM, Watson SJ, Akil H 1994 Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients. Arch Gen Psychiatry 51:701-707